Douglas E Onsi - Net Worth and Insider Trading
Douglas E Onsi Net Worth
The estimated net worth of Douglas E Onsi is at least $1 Million dollars as of 2024-05-04. Douglas E Onsi is the CFO, GC, Treasurer & Secretary, 10% Owner of Leap Therapeutics Inc and owns about 445,869 shares of Leap Therapeutics Inc (LPTX) stock worth over $1 Million. Details can be seen in Douglas E Onsi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas E Onsi has not made any transactions after 2019-02-05 and currently still holds the listed stock(s).
Transaction Summary of Douglas E Onsi
Douglas E Onsi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas E Onsi owns 2 companies in total, including Leap Therapeutics Inc (LPTX) , and TetraLogic Pharmaceuticals Corp (TLOG) .
Click here to see the complete history of Douglas E Onsi’s form 4 insider trades.
Insider Ownership Summary of Douglas E Onsi
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
LPTX | Leap Therapeutics Inc | 2019-02-05 | 10 percent owner & CFO,Gen Counsel,Treas & Sec. |
TLOG | TetraLogic Pharmaceuticals Corp | 2015-01-28 | director |
Douglas E Onsi Latest Holdings Summary
Douglas E Onsi currently owns a total of 1 stock. Douglas E Onsi owns 445,869 shares of Leap Therapeutics Inc (LPTX) as of February 5, 2019, with a value of $1 Million.
Latest Holdings of Douglas E Onsi
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LPTX | Leap Therapeutics Inc | 2019-02-05 | 445,869 | 3.19 | 1,422,322 |
Holding Weightings of Douglas E Onsi
Douglas E Onsi Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas E Onsi has made a total of 0 transactions in Leap Therapeutics Inc (LPTX) over the past 5 years. The most-recent trade in Leap Therapeutics Inc is the acquisition of 57,143 shares on February 5, 2019, which cost Douglas E Onsi around $999,999.
Insider Trading History of Douglas E Onsi
- 1
Douglas E Onsi Trading Performance
GuruFocus tracks the stock performance after each of Douglas E Onsi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas E Onsi is 13.8%. GuruFocus also compares Douglas E Onsi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas E Onsi within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas E Onsi's insider trading performs compared to the benchmark.
Performance of Douglas E Onsi
Douglas E Onsi Ownership Network
Ownership Network List of Douglas E Onsi
Ownership Network Relation of Douglas E Onsi
Douglas E Onsi Owned Company Details
What does Leap Therapeutics Inc do?
Who are the key executives at Leap Therapeutics Inc?
Douglas E Onsi is the 10 percent owner & CFO,Gen Counsel,Treas & Sec. of Leap Therapeutics Inc. Other key executives at Leap Therapeutics Inc include Chief Scientific Officer Jason Baum , 10 percent owner Beigene, Ltd. , and VP & Head of Reg Affairs/Qual Christine Granfield .
Leap Therapeutics Inc (LPTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Leap Therapeutics Inc (LPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Leap Therapeutics Inc (LPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Leap Therapeutics Inc (LPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Leap Therapeutics Inc Insider Transactions
Douglas E Onsi Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas E Onsi. You might contact Douglas E Onsi via mailing address: C/o Tolerrx Inc, 300 Technology Square, Cambridge Ma 02139.